During the past decade, Tropical Disease Foundation conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tropical Disease Foundation" #1 sponsor was "Clover Biopharmaceuticals AUS Pty Ltd" with 1 trials, followed by "Global Alliance for TB Drug Development" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tropical Disease Foundation" #1 collaborator was "Coalition for Epidemic Preparedness Innovations" with 1 trials as a collaborator, "International Vaccine Institute" with 1 trials as a collaborator, "National University Hospital, Singapore" with 1 trials as a collaborator and "Singapore Clinical Research Institute (SCRI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Tropical Disease Foundation" are "Tuberculosis, Pulmonary" (3 trials), "COVID-19" (1 trials), "Dengue" (1 trials), "Drug-Resistant Tuberculosis" (1 trials) and "Extensively Drug-Resistant Tuberculosis" (1 trials). Many other conditions were trialed in "Tropical Disease Foundation" in a lesser frequency.

Most popular intervention types in "Tropical Disease Foundation" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Bedaquiline" (2 trials), "Pyrazinamide" (2 trials), "Ad26.COV2.S" (1 trials) and "Clofazimine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Tropical Disease Foundation" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Tropical Disease Foundation". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Tropical Disease Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Tropical Disease Foundation, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Tropical Disease Foundation has several departments that took part in Clinical trials: "Tropical Disease Foundation" - 4 trials